Compare IDEXX Laboratories, Inc. (IDXX) vs Live Nation Entertainment, Inc. (LYV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Live Nation Entertainment, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Live Nation Entertainment, Inc. trades at $172.16 (market cap $39.92B). The key difference: IDEXX Laboratories, Inc. and Live Nation Entertainment, Inc. are close in size by market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Live Nation Entertainment, Inc. for 72 Days on average.
| IDXX | LYV | |
|---|---|---|
Market Cap | $40.43B | $39.92B |
Volume | 692,164 | 1,982,609 |
Sector | Health | Media |
52-Week High | $766.68 | $188.46 |
52-Week Low | $504.70 | $125.61 |
Typical Hold Time | 46 Days | 72 Days |
Enterprise Value | $41.32B | $42.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
LYV trades at $170.33, down 0.3% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported revenue of $25.20B in 2025, with net income of $496M, though margins remain thin at 1.96%. Recent news highlights strong fan demand and strategic partnerships, such as the Salesforce Agentforce expansion announced September 16, 2026. Analyst consensus is strongly bullish with a $208.18 price target, supported by 40 buy ratings.
The outlook for LYV is positive due to robust demand for live events and double-digit growth in deferred revenue, but risks include high valuation multiples, legal uncertainties from past DOJ scrutiny, and cost pressures. Earnings volatility is a concern after recent misses, though Q2 2026 beat expectations. Investors should weigh strong institutional support against execution risks in a competitive market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →
